Printer Friendly
The Free Library
14,506,803 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Parkinson's, Alzheimer's, and Diabetes Are Just Some of the Diseases That Are Expected to Benefit Form Stem-Cell Research.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c31634) has announced the addition of Applications of Stem Cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young  in Drug Discovery to their offering.

Business Implications

--The development of stem cells for therapeutic purposes, including cell therapy and regenerative re·gen·er·a·tive  
adj.
1. Of, relating to, or marked by regeneration.

2. Tending to regenerate.



re·gen
 medicine, is emerging as a major field of pharmaceutical research. Stem-cell technology is also making inroads inroads
Noun, pl

make inroads into to start affecting or reducing: my gambling has made great inroads into my savings

inroads npl to make inroads into [+
 in drug discovery. This technology offers great potential for understanding disease mechanisms and identifying targets. Pharmaceutical companies that successfully integrate stem-cell technologies will have a competitive advantage.

--Stem cells have numerous applications in drug discovery. They are important for understanding differentiation pathways, for identifying factors needed to manipulate cell lineages, for improving screening assays, and for identifying disease targets. The production of stem-cell-derived human hepatocytes will have an immediate impact on toxicology toxicology, study of poisons, or toxins, from the standpoint of detection, isolation, identification, and determination of their effects on the human body. Toxicology may be considered the branch of pharmacology devoted to the study of the poisonous effects of drugs.  and metabolism studies.

--Dozens of stem-cell companies are competing with one another and seeking collaborations with big pharmaceutical companies. Although the technology in these companies is still primarily in the research phase, some groups have demonstrated proof-of-concept for stem-cell technologies in animal models. Those companies that ultimately control the rights to stem cells and their uses will become dominant players. Companies that conduct stem-cell-based drug discovery and product development will achieve the greatest value.

--An important new approach in the stem-cell field is the creation of multidisciplinary research consortia of academic, medical, government, and industry partners. Although consortia could foster major advances, whether they will be able to translate basic research into the commercial arena is unclear. If successful, the consortia members will gain a major advantage in developing and applying stem-cell technology.

Stem cells are unspecialized cells that can differentiate into numerous types of specialized cells with specific functions. Diseases and disorders that might benefit from stem-cell research Noun 1. stem-cell research - research on stem cells and their use in medicine
biological research - scientific research conducted by biologists

embryonic stem-cell research - biological research on stem cells derived from embryos and on their use in medicine
 include Parkinson's, Alzheimer's, diabetes, cancer, heart disease, spinal cord injury Spinal Cord Injury Definition

Spinal cord injury is damage to the spinal cord that causes loss of sensation and motor control.
Description

Approximately 10,000 new spinal cord injuries (SCIs) occur each year in the United States.
, and multiple sclerosis, as well as organ transplantation The transfer of organs such as the kidneys, heart, or liver from one body to another.

The transplantation of human organs has become a common medical procedure. Typical organs transplanted are the kidneys, heart, liver, pancreas, cornea, skin, bones, and lungs.
 and wound treatment. Stem cells are also a valuable source of material in drug discovery, high-content screening High Content screening is an automated cell biology method drawing on optics, chemistry, biology and image analysis to permit rapid, highly parallel biological research and drug discovery.  assays, and toxicology studies.

In this Decision Resources report, we discuss the study of both undifferentiated undifferentiated /un·dif·fer·en·ti·at·ed/ (un-dif?er-en´she-at-ed) anaplastic.

un·dif·fer·en·ti·at·ed
adj.
Having no special structure or function; primitive; embryonic.
 stem cells and adult stem cells Adult stem cells are undifferentiated cells found throughout the body that divide to replenish dying cells and regenerate damaged tissues. Also known as somatic (from Greek Σωματικóς, of the body , the use of stem-cell biology to elucidate e·lu·ci·date  
v. e·lu·ci·dat·ed, e·lu·ci·dat·ing, e·lu·ci·dates

v.tr.
To make clear or plain, especially by explanation; clarify.

v.intr.
To give an explanation that serves to clarify.
 the pathways and mechanisms involved in different diseases, ongoing research to develop methods of using stem cells to replace disease-damaged cells, stem-cell-based drug discovery platforms, the use of stem cells in drug screening and toxicology, and the outlook for stem-cell-based drug discovery. We also profile companies and consortia involved in stem-cell research and examine the legal issues surrounding the field.

Topics Covered

Introduction

Overview of Stem Cells

Legal Issues

Stem-Cell Development

Adult Stem-Cell Research

Target Identification: Manipulating Differentiation Pathways

Stem-Cell Therapy vs. Cell Protection

Stem Cells in Cellular Assays for Screening

Stem-Cell-Based Drug Discovery Platforms

Drug Screening and Toxicology

Stem-Cell-Based Consortia

Outlook for Stem-Cell-Based Drug Discovery

Figure 1. Embyonic Stem Cells (ESCs) Differentiate into Any Cell Type

Table 1. Available Human Embryonic Stem-Cell Lines Eligible for Use with U.S. Federal Funding

Table 2. Select Companies Active in the Development and Application of Stem Cells

Table 3. Select Consortia and Institutes Involved in Stem-Cell Research

Companies Mentioned

--Aastrom Biosciences

--Advanced Cell Technology

--AmCyte

--Arteriocyte

--Athersys

--BeFutur Biotechnologies

--Cellartis

--Cellerant Therapeutics

--CNAssays

--CyThera

--Develogen

--Epiontis

For more information visit http://www.researchandmarkets.com/reports/c31634
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 16, 2006
Words:536
Previous Article:Business Engine Recognized as a Leader in Project Portfolio Management Market by Independent Research Firm.
Next Article:Deals between Biotechnology Companies and the Academic Sector Account for the Largest Growth in Licensing Activity.



Related Articles
Bush's Compassionless Conservatism.(Brief Article)
PROP. 71 WOULD STOP TOP RESEARCHERS' FLIGHT.(Editorial)(Editorial)
Lame claims for embryonic stem-cell research.(Between The Lines)
Stem winder.(LETTERS)(Letter to the Editor)
Embryonic stem cell research: accepting the knowledge and applying it to our lives.
Siding with science.(Editorials)(Frist comes out in favor of stem cell funding)(Editorial)
Stem cell breakthrough.(Editorials)(Research holds promise of resolving ethical issue)(Editorial)
Should stem-cell research receive federal funding? Congress is considering relaxing the rules for funding this controversial research.(DEBATE)
First time for everything.(Editorials)(Bush's first-ever veto will hurt some Republicans)(Editorial)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles